Growth Metrics

Rigel Pharmaceuticals (RIGL) Cash from Operations Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 37.40%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 20.11%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 16.64%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -7.60%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 34.32%
10 Rigel Pharmaceuticals 551.62 Mn 404.94 Mn 54.21 Mn 38.71%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 38.71%
Dec 31, 2025 44.28%
Sep 30, 2025 56.14%
Jun 30, 2025 63.43%
Mar 31, 2025 67.34%
Dec 31, 2024 40.27%
Sep 30, 2024 60.12%
Jun 30, 2024 -82.38%
Mar 31, 2024 36.90%
Dec 31, 2023 26.28%
Sep 30, 2023 58.83%
Jun 30, 2023 34.30%
Mar 31, 2023 -9.62%
Dec 31, 2022 -31.44%
Sep 30, 2022 3.15%
Jun 30, 2022 8.13%
Mar 31, 2022 -255.84%
Dec 31, 2021 -53.82%
Sep 30, 2021 19.96%
Jun 30, 2021 59.34%
Mar 31, 2021 5.16%
Dec 31, 2020 7.56%
Sep 30, 2020 -3.42%
Jun 30, 2020 10.33%
Mar 31, 2020 46.99%
Dec 31, 2019 8.18%
Sep 30, 2019 13.44%
Jun 30, 2019 3.33%
Mar 31, 2019 70.61%
Dec 31, 2018 41.68%
Sep 30, 2018 -28.53%
Jun 30, 2018 -14.16%
Mar 31, 2018 -48.89%
Dec 31, 2017 -9.53%
Sep 30, 2017 1.41%
Jun 30, 2017 0.80%
Mar 31, 2017 -8.12%
Dec 31, 2016 12.96%
Sep 30, 2016 -2.86%
Jun 30, 2016 4.73%
Mar 31, 2016 3.71%
Dec 31, 2015 13.84%
Sep 30, 2015 21.60%
Jun 30, 2015 4.36%
Mar 31, 2015 40.49%
Dec 31, 2014 7.00%
Sep 30, 2014 -12.83%
Jun 30, 2014 -5.13%
Mar 31, 2014 7.51%
Dec 31, 2013 -56.61%
Sep 30, 2013 -2.95%